James H. Mackaness - 28 Nov 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Financial Officer
Signature
/s/ James Mackaness
Issuer symbol
SLNO
Transactions as of
28 Nov 2023
Net transactions value
-$222,177
Form type
4
Filing time
30 Nov 2023, 21:52:04 UTC
Previous filing
13 Dec 2023
Next filing
04 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Sale $86,619 -3,205 -9.5% $27.03 30,365 28 Nov 2023 Direct F1, F2
transaction SLNO Common Stock Sale $18,571 -673 -2.2% $27.59 29,692 28 Nov 2023 Direct F1, F3
transaction SLNO Common Stock Sale $59,298 -2,162 -7.3% $27.43 27,530 29 Nov 2023 Direct F1, F4
transaction SLNO Common Stock Sale $57,689 -2,041 -7.4% $28.26 25,489 29 Nov 2023 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $26.465 to $27.46. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $27.465 to $28.34. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $26.89 to $27.885. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $27.89 to $28.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.